Charlie Richard
Director
Genetics
Oxyrane
Belgium
Biography
Dr. Richard was appointed to the board in June 2015 after having served as Chief Medical Officer with the Company since 2012. Before joining Oxyrane, Dr. Richard was Principal Medical Director and Head of Translational Medicine, Clinical R&D at Shire Human Genetic Therapies. He was previously VP & Head of the Department of Genomics at Wyeth and Assistant Professor of Psychiatry & Human Genetics at the University of Pittsburgh Medical Center. Dr. Richard holds a PhD and MD from Ohio State University School of Medicine and a BS in Biology from Stanford University.
Research Interest
Genetics
